These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20680325)

  • 21. Motor cortex excitability changes in mild Alzheimer's disease are reversed by donepezil.
    Balla C; Maertens de Noordhout A; Pepin JL
    Dement Geriatr Cogn Disord; 2014; 38(3-4):264-70. PubMed ID: 24969819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between motor cortex excitability and severity of Alzheimer's disease: a transcranial magnetic stimulation study.
    Khedr EM; Ahmed MA; Darwish ES; Ali AM
    Neurophysiol Clin; 2011 Jul; 41(3):107-13. PubMed ID: 21784322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New insights into Alzheimer's disease progression: a combined TMS and structural MRI study.
    Niskanen E; Könönen M; Määttä S; Hallikainen M; Kivipelto M; Casarotto S; Massimini M; Vanninen R; Mervaala E; Karhu J; Soininen H
    PLoS One; 2011; 6(10):e26113. PubMed ID: 22022529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Working memory load-related electroencephalographic parameters can differentiate progressive from stable mild cognitive impairment.
    Missonnier P; Deiber MP; Gold G; Herrmann FR; Millet P; Michon A; Fazio-Costa L; Ibañez V; Giannakopoulos P
    Neuroscience; 2007 Dec; 150(2):346-56. PubMed ID: 17996378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced cortical inhibition in first-episode schizophrenia.
    Wobrock T; Schneider M; Kadovic D; Schneider-Axmann T; Ecker UK; Retz W; Rösler M; Falkai P
    Schizophr Res; 2008 Oct; 105(1-3):252-61. PubMed ID: 18625547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative EEG in progressing vs stable mild cognitive impairment (MCI): results of a 1-year follow-up study.
    Luckhaus C; Grass-Kapanke B; Blaeser I; Ihl R; Supprian T; Winterer G; Zielasek J; Brinkmeyer J
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1148-55. PubMed ID: 18537220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.
    Grundman M; Petersen RC; Ferris SH; Thomas RG; Aisen PS; Bennett DA; Foster NL; Jack CR; Galasko DR; Doody R; Kaye J; Sano M; Mohs R; Gauthier S; Kim HT; Jin S; Schultz AN; Schafer K; Mulnard R; van Dyck CH; Mintzer J; Zamrini EY; Cahn-Weiner D; Thal LJ;
    Arch Neurol; 2004 Jan; 61(1):59-66. PubMed ID: 14732621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve.
    Querbes O; Aubry F; Pariente J; Lotterie JA; Démonet JF; Duret V; Puel M; Berry I; Fort JC; Celsis P;
    Brain; 2009 Aug; 132(Pt 8):2036-47. PubMed ID: 19439419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Motor cortex inhibitory circuits in dementia with Lewy bodies and in Alzheimer's disease.
    Nardone R; Bratti A; Tezzon F
    J Neural Transm (Vienna); 2006 Nov; 113(11):1679-84. PubMed ID: 17024328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in cortical thickness in healthy controls, subjects with mild cognitive impairment, and Alzheimer's disease patients: a longitudinal study.
    Julkunen V; Niskanen E; Koikkalainen J; Herukka SK; Pihlajamäki M; Hallikainen M; Kivipelto M; Muehlboeck S; Evans AC; Vanninen R; Hilkka Soininen
    J Alzheimers Dis; 2010; 21(4):1141-51. PubMed ID: 21504134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short latency afferent inhibition is not impaired in mild cognitive impairment.
    Sakuma K; Murakami T; Nakashima K
    Clin Neurophysiol; 2007 Jul; 118(7):1460-3. PubMed ID: 17462943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noninvasive brain stimulation in Alzheimer's disease: systematic review and perspectives for the future.
    Freitas C; Mondragón-Llorca H; Pascual-Leone A
    Exp Gerontol; 2011 Aug; 46(8):611-27. PubMed ID: 21511025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigating Neurophysiological Markers of Symptom Severity in Alzheimer's Disease.
    Hoy KE; Emonson MRL; Bailey NW; Humble G; Coyle H; Rogers C; Fitzgerald PB
    J Alzheimers Dis; 2022; 85(1):309-321. PubMed ID: 34806601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracortical inhibition and facilitation in migraine--a transcranial magnetic stimulation study.
    Siniatchkin M; Kröner-Herwig B; Kocabiyik E; Rothenberger A
    Headache; 2007 Mar; 47(3):364-70. PubMed ID: 17371353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia.
    Pierantozzi M; Panella M; Palmieri MG; Koch G; Giordano A; Marciani MG; Bernardi G; Stanzione P; Stefani A
    Clin Neurophysiol; 2004 Oct; 115(10):2410-8. PubMed ID: 15351384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcranial magnetic stimulation predicts cognitive decline in patients with Alzheimer's disease.
    Motta C; Di Lorenzo F; Ponzo V; Pellicciari MC; Bonnì S; Picazio S; Mercuri NB; Caltagirone C; Martorana A; Koch G
    J Neurol Neurosurg Psychiatry; 2018 Dec; 89(12):1237-1242. PubMed ID: 30464028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortical excitability varies across different muscles.
    Menon P; Kiernan MC; Vucic S
    J Neurophysiol; 2018 Sep; 120(3):1397-1403. PubMed ID: 29975162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotype (cystatin C) and EEG phenotype in Alzheimer disease and mild cognitive impairment: a multicentric study.
    Babiloni C; Benussi L; Binetti G; Bosco P; Busonero G; Cesaretti S; Dal Forno G; Del Percio C; Ferri R; Frisoni G; Ghidoni R; Rodriguez G; Squitti R; Rossini PM
    Neuroimage; 2006 Feb; 29(3):948-64. PubMed ID: 16213753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensory gating deficit assessed by P50/Pb middle latency event related potential in Alzheimer's disease.
    Cancelli I; Cadore IP; Merlino G; Valentinis L; Moratti U; Bergonzi P; Gigli GL; Valente M
    J Clin Neurophysiol; 2006 Oct; 23(5):421-5. PubMed ID: 17016152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motor cortex excitability in Alzheimer's disease: a transcranial magnetic stimulation follow-up study.
    Ferreri F; Pasqualetti P; Määttä S; Ponzo D; Guerra A; Bressi F; Chiovenda P; Del Duca M; Giambattistelli F; Ursini F; Tombini M; Vernieri F; Rossini PM
    Neurosci Lett; 2011 Apr; 492(2):94-8. PubMed ID: 21281700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.